Canada markets closed

Viridian Therapeutics, Inc. (VRDN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
15.40+0.82 (+5.62%)
At close: 04:00PM EDT
15.43 +0.03 (+0.19%)
After hours: 07:10PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 982.87M
Enterprise Value 733.06M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.20k
Price/Book (mrq)4.17
Enterprise Value/Revenue 2.33k
Enterprise Value/EBITDA -3.11

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 3-42.80%
S&P500 52-Week Change 322.38%
52 Week High 328.35
52 Week Low 310.93
50-Day Moving Average 316.81
200-Day Moving Average 317.46

Share Statistics

Avg Vol (3 month) 3906.33k
Avg Vol (10 day) 3895.36k
Shares Outstanding 563.82M
Implied Shares Outstanding 663.82M
Float 848.19M
% Held by Insiders 11.00%
% Held by Institutions 199.61%
Shares Short (Apr 15, 2024) 49.73M
Short Ratio (Apr 15, 2024) 49.72
Short % of Float (Apr 15, 2024) 417.90%
Short % of Shares Outstanding (Apr 15, 2024) 415.25%
Shares Short (prior month Mar 15, 2024) 47.62M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 13, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Nov 13, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-99,275.00%

Management Effectiveness

Return on Assets (ttm)-34.37%
Return on Equity (ttm)-56.80%

Income Statement

Revenue (ttm)314k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-31.40%
Gross Profit (ttm)N/A
EBITDA -253.93M
Net Income Avi to Common (ttm)-237.73M
Diluted EPS (ttm)-5.31
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)477.37M
Total Cash Per Share (mrq)7.61
Total Debt (mrq)22.04M
Total Debt/Equity (mrq)4.99%
Current Ratio (mrq)18.26
Book Value Per Share (mrq)4.36

Cash Flow Statement

Operating Cash Flow (ttm)-184.17M
Levered Free Cash Flow (ttm)-102.82M